Riverwater Partners’s Boston Scientific BSX Stock Holding History

Riverwater Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,309	Closed	-$220K	–	216
2025 Q4	$220K	Sell	2,309 -592	-20%	-$58K	0.09%	198
2025 Q3	$283K	Sell	2,901 -203	-7%	-$21K	0.12%	188
2025 Q2	$333K	Buy	3,104 +98	+3%	+$9.92K	0.16%	156
2025 Q1	$303K	Sell	3,006 -25	-0.8%	-$2.52K	0.16%	152
2024 Q4	$271K	Buy	3,031 +10	+0.3%	+$880	0.13%	185
2024 Q3	$255K	Sell	3,021 -29	-1%	-$2.29K	0.13%	184
2024 Q2	$235K	Sell	3,050 -2	-0.1%	-$146	0.17%	163
2024 Q1	$209K	Sell	3,052 -1,468	-32%	-$94.4K	0.15%	182
2023 Q4	$261K	Sell	4,520 -170	-4%	-$9.07K	0.21%	160
2023 Q3	$248K	Buy	4,690 +110	+2%	+$5.77K	0.23%	158
2023 Q2	$248K	Sell	4,580 -400	-8%	-$20.9K	0.22%	154
2023 Q1	$249K	Buy	+4,980	New	+$235K	0.23%	146

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Riverwater Partners's BSX Position: Q1 2026 in Review

Riverwater Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,309 shares — an estimated $220K sold.

Riverwater Partners first reported a position in BSX in Q1 2023 and held it in 12 quarters. The position peaked at $333K in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Riverwater Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Riverwater Partners sold 2,309 Boston Scientific shares in Q1 2026, an estimated $220K.
Riverwater Partners first reported a position in Boston Scientific in Q1 2023 and held it in 12 quarters.
Riverwater Partners's Boston Scientific position peaked at $333K in Q2 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Riverwater Partners's 13F filing for Q1 2026, filed 8 May 2026.